4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0002044770-26-000006
Director sold 2,954 shares at $62.08 ($183,384)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goodrich Katherine · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Sale : show line 1 in the form 10b5-1 | −2,954 | $62.08 | $183,384 | 2,233 | D |
| Open-market sales · 2,954 sh · avg $62.08 · $183,384 | ||||||
Loading xslF345X06/wk-form4_1781727435.xml…